MAP Pharmaceuticals to Present at the 2008 RBC Capital Markets Healthcare Conference -
MAP Pharmaceuticals, Inc. (MAPP) Corporate Event Announcement Notice -
MAPP: To Present At Lazard Capital Healthcare Conference @ 09:55 ET [delayed] -
Map Pharmaceuticals shares plunge on weak Q3 results -
MAP Pharmaceuticals Drops On Q3 Loss -
BRIEF-MAP Pharmaceuticals Q3 results -
MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results -
MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference -
MAPP: Completes Phase 3 Enrollment for Unit Dose Budesonide in Pediatric Asthma -
MAP Pharmaceuticals announces new appointment -
MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results -
MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion -
MAPP: Begins Phase 3 Trial of MAP0004 for Migraine -
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine -
MAPP: Presents Data from In-vitro Study of MAP0004 for Migraines -
MAPP: To Present At Goldman Sachs Healthcare Conference @ 19:00 ET [delayed] -
MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference -